ChemT Biotechnology raises US$4 million seed round led by Wavemaker Ventures

  • ChemT Biotechnology raised USD 5 million in 18 months, including a USD 4 million seed round led by Wavemaker Pacific Partners Pte Ltd.
  • The seed round included co-investment from SEEDS, an SG Growth Capital arm, with additional backing from US and Asian investors.
  • ChemT develops AI tools and small molecules to improve biomanufacturing, aiming to boost yields, cut timelines, lower costs, improve scalability.
  • Proceeds earmarked for expanding AI and lab infrastructure, advancing AI-designed molecular products toward GMP readiness, scaling commercial partnerships.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wavemaker Pacific Partners Pte Ltd. published the original content used to generate this news brief on June 22, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.